Literature DB >> 11238634

Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase.

T F Gajewski1, F Fallarino, P E Fields, F Rivas, M L Alegre.   

Abstract

To examine the role of CTLA-4 in controlling Ag-specific CD8(+) T cell activation, TCR-transgenic/CTLA-4 wild-type or -deficient mice were generated in a recombination-activating gene 2-deficient background. Naive T cells from these mice responded comparably whether or not CTLA-4 was expressed. In contrast, primed T cells responded more vigorously if they lacked CTLA-4 expression. We took advantage of the difference between naive and primed T cell responses to approach the mechanism of CTLA-4 function. Single-cell analyses demonstrated that a greater fraction of CTLA-4-deficient cells responded to a fixed dose of Ag compared with CTLA-4-expressing cells, whereas the magnitude of response per cell was comparable. A shift in the dose-response curve to APCs was also observed such that fewer APCs were required to activate CTLA-4-deficient T cells to produce intracellular IFN-gamma and to proliferate. These results suggest that CTLA-4 controls the threshold of productive TCR signaling. Biochemical analysis comparing stimulated naive and primed TCR-transgenic cells revealed no obvious differences in expression of total CTLA-4, tyrosine-phosphorylated CTLA-4, and associated Src homology domain 2-containing protein tyrosine phosphatase. Thus, the biochemical mechanism explaining the differential inhibitory effect of CTLA-4 on naive and primed CD8(+) T cells remains unclear.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238634     DOI: 10.4049/jimmunol.166.6.3900

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Frontline Science: PECAM-1 (CD31) expression in naïve and memory, but not acutely activated, CD8+ T cells.

Authors:  Debra K Newman; Guoping Fu; Laura McOlash; David Schauder; Peter J Newman; Weiguo Cui; Sridhar Rao; Bryon D Johnson; Jill A Gershan; Matthew J Riese
Journal:  J Leukoc Biol       Date:  2018-07-31       Impact factor: 4.962

2.  The role of checkpoints in the treatment of GBM.

Authors:  Jennifer E Kim; Michael Lim
Journal:  J Neurooncol       Date:  2015-03-07       Impact factor: 4.130

3.  CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependent.

Authors:  Luca Gattinoni; Anju Ranganathan; Deborah R Surman; Douglas C Palmer; Paul A Antony; Marc R Theoret; David M Heimann; Steven A Rosenberg; Nicholas P Restifo
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

Review 4.  Co-inhibitory blockade while preserving tolerance: checkpoint inhibitors for glioblastoma.

Authors:  Liliana E Lucca; David A Hafler
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

5.  Upregulation of Immune Checkpoint Molecules, PD-1 and LAG-3, on CD4+ and CD8+ T Cells after Gastric Cancer Surgery.

Authors:  Seigo Takaya; Hiroaki Saito; Masahide Ikeguchi
Journal:  Yonago Acta Med       Date:  2015-03-27       Impact factor: 1.641

6.  Global T cell dysregulation in non-autoimmune-prone mice promotes rapid development of BAFF-independent, systemic lupus erythematosus-like autoimmunity.

Authors:  William Stohl; Noam Jacob; William J Quinn; Michael P Cancro; Huaxin Gao; Chaim Putterman; Xiaoni Gao; Luminita Pricop; Michael N Koss
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

7.  Enhanced effector responses in activated CD8+ T cells deficient in diacylglycerol kinases.

Authors:  Matthew J Riese; Liang-Chuan S Wang; Edmund K Moon; Rohan P Joshi; Anjana Ranganathan; Carl H June; Gary A Koretzky; Steven M Albelda
Journal:  Cancer Res       Date:  2013-04-10       Impact factor: 12.701

8.  LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems.

Authors:  Joseph F Grosso; Cristin C Kelleher; Timothy J Harris; Charles H Maris; Edward L Hipkiss; Angelo De Marzo; Robert Anders; George Netto; Derese Getnet; Tullia C Bruno; Monica V Goldberg; Drew M Pardoll; Charles G Drake
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

9.  PAG/Cbp suppression reveals a contribution of CTLA-4 to setting the activation threshold in T cells.

Authors:  Michal Smida; Clemens Cammann; Slavyana Gurbiel; Nadja Kerstin; Holger Lingel; Sabine Lindquist; Luca Simeoni; Monika C Brunner-Weinzierl; Miloslav Suchanek; Burkhart Schraven; Jonathan A Lindquist
Journal:  Cell Commun Signal       Date:  2013-04-19       Impact factor: 5.712

10.  CTLA-4-Tg/CD-28-KO Mice Exhibit Reduced T Cell Proliferation in vivo Compared to CD-28-KO Mice in a Graft-versus-host Disease Model.

Authors:  Jong-Sun Yoo; Yun-Jung Lee; Joo Won Yoon; Kyeong Eun Hyung; Kwang Woo Hwang
Journal:  Korean J Physiol Pharmacol       Date:  2012-10-18       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.